Ral-specific Guanine Nucleotide Exchange Factor Activity Opposes Other Ras Effectors in PC12 Cells by Inhibiting Neurite Outgrowth
Overview
Authors
Affiliations
Ras proteins can activate at least three classes of downstream target proteins: Raf kinases, phosphatidylinositol-3 phosphate (PI3) kinase, and Ral-specific guanine nucleotide exchange factors (Ral-GEFs). In NIH 3T3 cells, activated Ral-GEFs contribute to Ras-induced cell proliferation and oncogenic transformation by complementing the activities of Raf and PI3 kinases. In PC12 cells, activated Raf and PI3 kinases mediate Ras-induced cell cycle arrest and differentiation into a neuronal phenotype. Here, we show that in PC12 cells, Ral-GEF activity acts opposite to other Ras effectors. Elevation of Ral-GEF activity induced by transfection of a mutant Ras protein that preferentially activates Ral-GEFs, or by transfection of the catalytic domain of the Ral-GEF Rgr, suppressed cell cycle arrest and neurite outgrowth induced by nerve growth factor (NGF) treatment. In addition, Rgr reduced neurite outgrowth induced by a mutant Ras protein that preferentially activates Raf kinases. Furthermore, inhibition of Ral-GEF activity by expression of a dominant negative Ral mutant accelerated cell cycle arrest and enhanced neurite outgrowth in response to NGF treatment. Ral-GEF activity may function, at least in part, through inhibition of the Rho family GTPases, CDC42 and Rac. In contrast to Ras, which was activated for hours by NGF treatment, Ral was activated for only approximately 20 min. These findings suggest that one function of Ral-GEF signaling induced by NGF is to delay the onset of cell cycle arrest and neurite outgrowth induced by other Ras effectors. They also demonstrate that Ras has the potential to promote both antidifferentiation and prodifferentiation signaling pathways through activation of distinct effector proteins. Thus, in some cell types the ratio of activities among Ras effectors and their temporal regulation may be important determinants for cell fate decisions between proliferation and differentiation.
Shin H, Braendle C, Monahan K, Kaplan R, Zand T, Mote F PLoS Genet. 2019; 15(5):e1008056.
PMID: 31086367 PMC: 6534338. DOI: 10.1371/journal.pgen.1008056.
Pituitary somatolactotropes evade an oncogenic response to Ras.
Roof A, Trudeau T, Gutierrez-Hartmann A Mol Cell Endocrinol. 2018; 476:165-172.
PMID: 29753028 PMC: 6120793. DOI: 10.1016/j.mce.2018.05.006.
Ganapathy S, Fagman J, Shen L, Yu T, Zhou X, Dai W Oncotarget. 2016; 7(51):84326-84337.
PMID: 27741517 PMC: 5356664. DOI: 10.18632/oncotarget.12607.
A Genome-Wide Association Study of Attention Function in a Population-Based Sample of Children.
Alemany S, Vilor-Tejedor N, Bustamante M, Pujol J, Macia D, Martinez-Vilavella G PLoS One. 2016; 11(9):e0163048.
PMID: 27656889 PMC: 5033492. DOI: 10.1371/journal.pone.0163048.
Dual effects of Ral-activated pathways on p27 localization and TGF-β signaling.
Tazat K, Harsat M, Goldshmid-Shagal A, Ehrlich M, Henis Y Mol Biol Cell. 2013; 24(11):1812-24.
PMID: 23576547 PMC: 3667732. DOI: 10.1091/mbc.E13-01-0007.